Align isocitrate dehydrogenase (NADP+) (EC 1.1.1.42) (characterized)
to candidate WP_011383051.1 AMB_RS03140 isocitrate dehydrogenase (NADP(+))
Query= BRENDA::B7GQR3 (406 letters) >NCBI__GCF_000009985.1:WP_011383051.1 Length = 406 Score = 602 bits (1553), Expect = e-177 Identities = 292/404 (72%), Positives = 342/404 (84%), Gaps = 2/404 (0%) Query: 1 MAKIKVEGTVVELDGDEMTRVIWKDIKDRLILPYLDVNLDYYDLGIEHRDETDDQVTIDA 60 M KIKV +VELDGDEMTR+IWK IKD+LILPYLDV+L YYDLGIE+RD+TDD+VTI+A Sbjct: 1 MNKIKVANPIVELDGDEMTRIIWKFIKDKLILPYLDVDLKYYDLGIEYRDKTDDKVTIEA 60 Query: 61 AHAIQKHHVGVKCATITPDEARVKEFGLKKMWKSPNGTIRNILGGTIFREPIVMSNVPRL 120 + AI+K+ VGVKCATITPDEARVKEF LKKMWKSPNGTIRNIL GT+FREPI+ NVPRL Sbjct: 61 SEAIKKYGVGVKCATITPDEARVKEFNLKKMWKSPNGTIRNILDGTVFREPIICKNVPRL 120 Query: 121 VPGWTKPIVVARHAFGDQYKATDFKVPGAGQLTVTFTPDDGSEPIQHVVYNYGEDGGVAQ 180 VPGWTKPIV+ RHAFGDQYKATDF VPG G+LT+ F +G E I+H V+++ GVA Sbjct: 121 VPGWTKPIVIGRHAFGDQYKATDFTVPGPGKLTIKFVGTNG-ETIEHEVFDF-PGAGVAM 178 Query: 181 VQYNVNDSIRGFARACFNYGLMRHYPVYLSTKNTILKAYDGQFKDIFAEVFETEYKDKYA 240 YN+++SI GFARAC NYG + +PVYLSTKNTILKAYDG+FKDIF EV+E E+K +YA Sbjct: 179 GMYNLDESIYGFARACLNYGQQKKWPVYLSTKNTILKAYDGRFKDIFQEVYEKEFKAEYA 238 Query: 241 EAGLTYEHRLIDDMVASSLKWHGGYIWACKNYDGDVQSDSVAQGFGSLGLMTSVLMTPDG 300 + G+TYEHRLIDDMVAS+LKW G ++WACKNYDGDVQSD+VAQGFGSLGLMTSVLM+PDG Sbjct: 239 KLGITYEHRLIDDMVASALKWSGEFVWACKNYDGDVQSDTVAQGFGSLGLMTSVLMSPDG 298 Query: 301 QTVESEAAHGTVTRHYRRWQKGEKTSTNPIASIFAWTGGLKHRADLDGTPEVRHFAKTLE 360 + VE+EAAHGTVTRHYR QKG++TSTNPIASIFAWT GL +RA D TPEV FA+ LE Sbjct: 299 KVVEAEAAHGTVTRHYREHQKGKETSTNPIASIFAWTRGLFYRAQFDNTPEVAKFAQALE 358 Query: 361 KVIVDTVEGGQMTKDLAMLIGPDEPWLDTDGFMNALDENLAKAL 404 +V V+TVE G MTKDLA+LIGP + WL T F++ LDENL K + Sbjct: 359 EVCVETVESGFMTKDLAILIGPGQSWLTTQQFLDKLDENLKKRM 402 Lambda K H 0.318 0.136 0.416 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 681 Number of extensions: 24 Number of successful extensions: 3 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 406 Length of database: 406 Length adjustment: 31 Effective length of query: 375 Effective length of database: 375 Effective search space: 140625 Effective search space used: 140625 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.3 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 50 (23.9 bits)
Align candidate WP_011383051.1 AMB_RS03140 (isocitrate dehydrogenase (NADP(+)))
to HMM TIGR00127 (isocitrate dehydrogenase, NADP-dependent (EC 1.1.1.42))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.carbon/TIGR00127.hmm # target sequence database: /tmp/gapView.27561.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR00127 [M=409] Accession: TIGR00127 Description: nadp_idh_euk: isocitrate dehydrogenase, NADP-dependent Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 6.1e-221 719.1 0.2 7.1e-221 718.9 0.2 1.0 1 lcl|NCBI__GCF_000009985.1:WP_011383051.1 AMB_RS03140 isocitrate dehydroge Domain annotation for each sequence (and alignments): >> lcl|NCBI__GCF_000009985.1:WP_011383051.1 AMB_RS03140 isocitrate dehydrogenase (NADP(+)) # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 718.9 0.2 7.1e-221 7.1e-221 2 407 .. 3 402 .. 2 404 .. 0.99 Alignments for each domain: == domain 1 score: 718.9 bits; conditional E-value: 7.1e-221 TIGR00127 2 kikvanpvveldgdemtriiwelikdklilpyleldlkyydlsvesrdatndkvtkdaaeaikkynvav 70 kikvanp+veldgdemtriiw+ ikdklilpyl++dlkyydl++e+rd+t+dkvt +a+eaikky+v+v lcl|NCBI__GCF_000009985.1:WP_011383051.1 3 KIKVANPIVELDGDEMTRIIWKFIKDKLILPYLDVDLKYYDLGIEYRDKTDDKVTIEASEAIKKYGVGV 71 9******************************************************************** PP TIGR00127 71 kcatitpdearvkefklkkmwkspngtirnilggtvfrepiiikriprlvprwekpiiigrhafgdqyk 139 kcatitpdearvkef+lkkmwkspngtirnil+gtvfrepii+k++prlvp+w+kpi+igrhafgdqyk lcl|NCBI__GCF_000009985.1:WP_011383051.1 72 KCATITPDEARVKEFNLKKMWKSPNGTIRNILDGTVFREPIICKNVPRLVPGWTKPIVIGRHAFGDQYK 140 ********************************************************************* PP TIGR00127 140 atdvvvpgpgklklvykpkdgaekvdlkvydyeeeggvalamyntdesiedfakaslklalekklplyl 208 atd+ vpgpgkl + ++ + +e+++ +v+d+++ g va++myn desi +fa+a l+ +kk+p+yl lcl|NCBI__GCF_000009985.1:WP_011383051.1 141 ATDFTVPGPGKLTIKFVGTN-GETIEHEVFDFPGAG-VAMGMYNLDESIYGFARACLNYGQQKKWPVYL 207 ****************9875.6899*********98.******************************** PP TIGR00127 209 stkntilkkydgrfkdifqevyekqykskfealgiwyehrliddmvaqalkskggyilalknydgdvqs 277 stkntilk ydgrfkdifqevyek++k + +lgi yehrliddmva alk g +++a+knydgdvqs lcl|NCBI__GCF_000009985.1:WP_011383051.1 208 STKNTILKAYDGRFKDIFQEVYEKEFKAEYAKLGITYEHRLIDDMVASALKWSGEFVWACKNYDGDVQS 276 ********************************************************************* PP TIGR00127 278 divaqgfgslglmtsvlvtpdgktveaeaahgtvtrhyrkyqkgeetstnsiasifawsrgllkrakld 346 d+vaqgfgslglmtsvl++pdgk veaeaahgtvtrhyr++qkg+etstn+iasifaw+rgl ra++d lcl|NCBI__GCF_000009985.1:WP_011383051.1 277 DTVAQGFGSLGLMTSVLMSPDGKVVEAEAAHGTVTRHYREHQKGKETSTNPIASIFAWTRGLFYRAQFD 345 ********************************************************************* PP TIGR00127 347 ntaelvkfaeilesatietveegimtkdlalilkksklersayltteefldaveerlkkkl 407 nt+e++kfa++le++++etve+g+mtkdla++++ +++ltt++fld+++e+lkk++ lcl|NCBI__GCF_000009985.1:WP_011383051.1 346 NTPEVAKFAQALEEVCVETVESGFMTKDLAILIGPG----QSWLTTQQFLDKLDENLKKRM 402 *********************************998....89****************986 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (409 nodes) Target sequences: 1 (406 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.01u 0.01s 00:00:00.02 Elapsed: 00:00:00.01 # Mc/sec: 10.88 // [ok]
This GapMind analysis is from Sep 17 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see the paper from 2019 on GapMind for amino acid biosynthesis, the paper from 2022 on GapMind for carbon sources, or view the source code.
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory